These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell-Specific Single Viral Vector CRISPR/Cas9 Editing and Genetically Encoded Tool Delivery in the Central and Peripheral Nervous Systems. Moffa JC; Bland IN; Tooley JR; Kalyanaraman V; Heitmeier M; Creed MC; Copits BA eNeuro; 2024 Jul; 11(7):. PubMed ID: 38871457 [TBL] [Abstract][Full Text] [Related]
4. Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES. Delluc-Clavières A; Le Bec C; Van den Berghe L; Conte C; Allo V; Danos O; Prats AC Gene Ther; 2008 Aug; 15(15):1090-8. PubMed ID: 18369321 [TBL] [Abstract][Full Text] [Related]
5. CRISPR genome engineering and viral gene delivery: a case of mutual attraction. Schmidt F; Grimm D Biotechnol J; 2015 Feb; 10(2):258-72. PubMed ID: 25663455 [TBL] [Abstract][Full Text] [Related]
6. The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system. Hutson TH; Kathe C; Menezes SC; Rooney MC; Bueler H; Moon LD Methods Mol Biol; 2014; 1162():189-207. PubMed ID: 24838969 [TBL] [Abstract][Full Text] [Related]
7. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology. Luis A Viruses; 2020 Sep; 12(10):. PubMed ID: 33003492 [TBL] [Abstract][Full Text] [Related]
8. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634 [TBL] [Abstract][Full Text] [Related]
9. Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector. Lai Z; Brady RO J Neurosci Res; 2002 Feb; 67(3):363-71. PubMed ID: 11813241 [TBL] [Abstract][Full Text] [Related]
10. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187 [TBL] [Abstract][Full Text] [Related]
11. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Furler S; Paterna JC; Weibel M; Büeler H Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934 [TBL] [Abstract][Full Text] [Related]
13. Selective protein expression within the CNS using hybrid lentivirus. Gussing F; van Marion I; Ralets I; Lundberg C Methods Mol Biol; 2009; 515():215-26. PubMed ID: 19378131 [TBL] [Abstract][Full Text] [Related]
14. pLR: a lentiviral backbone series to stable transduction of bicistronic genes and exchange of promoters. Vargas JE; Salton G; Sodré de Castro Laino A; Pires TD; Bonamino M; Lenz G; Delgado-Cañedo A Plasmid; 2012 Nov; 68(3):179-85. PubMed ID: 22728068 [TBL] [Abstract][Full Text] [Related]
15. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein. Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473 [TBL] [Abstract][Full Text] [Related]
17. Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production. Bagnis C; Zwojsczyki G; Chiaroni J; Bailly P Biotechniques; 2014 Jun; 56(6):311-2, 314-8. PubMed ID: 24924391 [TBL] [Abstract][Full Text] [Related]
18. Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide. Karnan S; Ota A; Konishi Y; Wahiduzzaman M; Hosokawa Y; Konishi H Nucleic Acids Res; 2016 Apr; 44(6):e54. PubMed ID: 26657635 [TBL] [Abstract][Full Text] [Related]
19. Viral vectors expressing a single microRNA-based short-hairpin RNA result in potent gene silencing in vitro and in vivo. Osório L; Gijsbers R; Oliveras-Salvá M; Michiels A; Debyser Z; Van den Haute C; Baekelandt V J Biotechnol; 2014 Jan; 169():71-81. PubMed ID: 24252659 [TBL] [Abstract][Full Text] [Related]
20. Key to Delivery: The (Epi-)genome Editing Vector Toolbox. Just S; Büning H Methods Mol Biol; 2018; 1767():147-166. PubMed ID: 29524133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]